Ustusorane B

Details

Top
Internal ID 63c8bed5-051e-4cd4-ac70-1574212d8743
Taxonomy Organoheterocyclic compounds > Benzopyrans > 2-benzopyrans
IUPAC Name 7-methyl-2-propan-2-ylidene-9H-furo[3,2-h]isochromen-3-one
SMILES (Canonical) CC1=CC2=C(CO1)C3=C(C=C2)C(=O)C(=C(C)C)O3
SMILES (Isomeric) CC1=CC2=C(CO1)C3=C(C=C2)C(=O)C(=C(C)C)O3
InChI InChI=1S/C15H14O3/c1-8(2)14-13(16)11-5-4-10-6-9(3)17-7-12(10)15(11)18-14/h4-6H,7H2,1-3H3
InChI Key OOSHVFPYQURYMZ-UHFFFAOYSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H14O3
Molecular Weight 242.27 g/mol
Exact Mass 242.094294304 g/mol
Topological Polar Surface Area (TPSA) 35.50 Ų
XlogP 3.40
Atomic LogP (AlogP) 3.45
H-Bond Acceptor 3
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
CHEMBL1078203

2D Structure

Top
2D Structure of Ustusorane B

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 1.0000 100.00%
Caco-2 + 0.8376 83.76%
Blood Brain Barrier + 0.6500 65.00%
Human oral bioavailability + 0.5429 54.29%
Subcellular localzation Mitochondria 0.8058 80.58%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9504 95.04%
OATP1B3 inhibitior + 0.9776 97.76%
MATE1 inhibitior - 0.8400 84.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior + 0.5579 55.79%
P-glycoprotein inhibitior - 0.8875 88.75%
P-glycoprotein substrate - 0.8189 81.89%
CYP3A4 substrate - 0.5159 51.59%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8469 84.69%
CYP3A4 inhibition - 0.5326 53.26%
CYP2C9 inhibition + 0.6024 60.24%
CYP2C19 inhibition + 0.8965 89.65%
CYP2D6 inhibition - 0.7285 72.85%
CYP1A2 inhibition + 0.9680 96.80%
CYP2C8 inhibition - 0.8725 87.25%
CYP inhibitory promiscuity + 0.8970 89.70%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6472 64.72%
Eye corrosion - 0.9808 98.08%
Eye irritation + 0.8273 82.73%
Skin irritation - 0.6495 64.95%
Skin corrosion - 0.9421 94.21%
Ames mutagenesis + 0.5500 55.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5060 50.60%
Micronuclear - 0.5600 56.00%
Hepatotoxicity + 0.7199 71.99%
skin sensitisation + 0.4752 47.52%
Respiratory toxicity + 0.6889 68.89%
Reproductive toxicity + 0.6889 68.89%
Mitochondrial toxicity - 0.7250 72.50%
Nephrotoxicity + 0.6694 66.94%
Acute Oral Toxicity (c) III 0.6210 62.10%
Estrogen receptor binding + 0.8459 84.59%
Androgen receptor binding - 0.4821 48.21%
Thyroid receptor binding - 0.5480 54.80%
Glucocorticoid receptor binding + 0.5862 58.62%
Aromatase binding + 0.7297 72.97%
PPAR gamma + 0.5404 54.04%
Honey bee toxicity - 0.8573 85.73%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.5600 56.00%
Fish aquatic toxicity + 0.9823 98.23%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL1951 P21397 Monoamine oxidase A 97.97% 91.49%
CHEMBL2581 P07339 Cathepsin D 95.45% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 94.59% 95.56%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 92.89% 91.11%
CHEMBL2039 P27338 Monoamine oxidase B 88.92% 92.51%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 88.90% 99.23%
CHEMBL1806 P11388 DNA topoisomerase II alpha 87.84% 89.00%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 85.92% 93.40%
CHEMBL3401 O75469 Pregnane X receptor 85.52% 94.73%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 82.72% 85.14%
CHEMBL4208 P20618 Proteasome component C5 81.49% 90.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 80.93% 86.33%
CHEMBL2378 P30307 Dual specificity phosphatase Cdc25C 80.76% 96.67%
CHEMBL1994 P08235 Mineralocorticoid receptor 80.74% 100.00%

Cross-Links

Top
PubChem 44557645
NPASS NPC217914
LOTUS LTS0070314
wikiData Q77559323